000016901 001__ 16901
000016901 005__ 20240709081614.0
000016901 0247_ $$2pmid$$apmid:20347551
000016901 0247_ $$2DOI$$a10.1007/s10971-010-2321-7
000016901 0247_ $$2WOS$$aWOS:000285974700008
000016901 037__ $$aPreJuSER-16901
000016901 041__ $$aeng
000016901 082__ $$a600
000016901 084__ $$2WoS$$aMaterials Science, Ceramics
000016901 1001_ $$0P:(DE-Juel1)VDB68378$$aDippel, A.-C.$$b0$$uFZJ
000016901 245__ $$aPbTiO3 nanoparticle precursors for chemical solution deposited electroceramic thin films
000016901 260__ $$aDordrecht [u.a.]$$bSpringer Science + Business Media B.V$$c2011
000016901 300__ $$a36 - 42
000016901 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article
000016901 3367_ $$2DataCite$$aOutput Types/Journal article
000016901 3367_ $$00$$2EndNote$$aJournal Article
000016901 3367_ $$2BibTeX$$aARTICLE
000016901 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000016901 3367_ $$2DRIVER$$aarticle
000016901 440_0 $$014361$$aJournal of Sol-Gel Science and Technology$$v57$$x0928-0707$$y1
000016901 500__ $$3POF3_Assignment on 2016-02-29
000016901 500__ $$aRecord converted from VDB: 12.11.2012
000016901 520__ $$aThe Vascular Registry (VR) on carotid procedures collects long-term outcomes on carotid artery stenting (CAS) and carotid endarterectomy (CEA) patients. The purpose of this report is to describe in-hospital and 30-day CAS outcomes in patients with atherosclerotic carotid artery disease (CAD; atherosclerosis [ATH]) compared to recurrent carotid stenosis (RES) and radiation-induced stenosis (RAD).The VR collects provider-reported data on CAS using a Web-based data management system. For this report, data were analyzed at the preprocedure, procedure, predischarge, and 30-day intervals.As of November 20, 2008, there were 4017 patients with CAS with discharge data, of which 72% were due to ATH. A total of 2321 patients were available for 30-day outcomes analysis (1623 ATH, 529 restenosis, 119 radiation, 17 dissection, 3 trauma, and 30 other). Baseline demographics showed that ATH occurred in older patients (72-years-old), had the greatest history of coronary artery disease (CAD; 62%), myocardial infarction (MI; 24%), valvular heart disease (8%), arrhythmia (16%), congestive heart failure (CHF; 16%), diabetes mellitus (DM; 35%), and chronic obstructive pulmonary disease (COPD; 20%). RES had a higher degree of baseline stenosis (87.0 vs 85.8 ATH; P = .010), were less likely to be symptomatic (35.5% vs 46.3% ATH; P < .001), but had a greater history of hypertension, peripheral vascular disease (PVD), and smoking. RAD was seen in younger patients (66.6 vs 71.7 ATH; P < .001), were more likely to be male (78.2% vs 60.9% ATH; P < .001), and had less comorbidities overall, with the exception of amaurosis fugax, smoking, and cancer. The only statistically significant difference in perioperative rates was in transient ischemic attack (TIA; 2.7% ATH vs 0.9% RES; P = .02). There were no statistically significant differences in in-hospital death/stroke/MI (ATH 5.4%, RES 3.8%, RAD 4.2%) or at 30 days (ATH 7.1%, RES 5.1%, RAD 5.0%). Even after adjusting for age, gender, symptomatology, CHF, and renal failure, the only statistically significant difference at 30 days was amaurosis fugax between ATH and RAD (odds ratio [OR] 0.13; P = .01).Although patients with ATH have statistically significant comorbidities, they did not have statistically significant increased rates of death/stroke/MI during hospitalization or within 30 days after discharge when compared to RES or RAD. The CAS event rates for ATH vs RES and RAD are similar, despite prior published reports. Symptomatic ATH have statistically significant higher rates of death/stroke/MI compared to asymptomatic cohort. Finally, consistent and accurate entry of long-term data beyond initial hospitalization is essential to fully assess CAS outcomes since a significant number of adverse events occur in the interval from hospital discharge to 30 days.
000016901 536__ $$0G:(DE-Juel1)FUEK491$$2G:(DE-HGF)$$aAtmosphäre und Klima$$cP23$$x0
000016901 536__ $$0G:(DE-Juel1)FUEK412$$aGrundlagen für zukünftige Informationstechnologien$$cP42$$x1
000016901 588__ $$aDataset connected to Web of Science, Pubmed
000016901 650_2 $$2MeSH$$aAged
000016901 650_2 $$2MeSH$$aAged, 80 and over
000016901 650_2 $$2MeSH$$aAnalysis of Variance
000016901 650_2 $$2MeSH$$aAngioplasty: instrumentation
000016901 650_2 $$2MeSH$$aAngioplasty: methods
000016901 650_2 $$2MeSH$$aAngioplasty: mortality
000016901 650_2 $$2MeSH$$aAtherosclerosis: pathology
000016901 650_2 $$2MeSH$$aAtherosclerosis: surgery
000016901 650_2 $$2MeSH$$aAtherosclerosis: ultrasonography
000016901 650_2 $$2MeSH$$aCarotid Stenosis: mortality
000016901 650_2 $$2MeSH$$aCarotid Stenosis: pathology
000016901 650_2 $$2MeSH$$aCarotid Stenosis: surgery
000016901 650_2 $$2MeSH$$aCarotid Stenosis: ultrasonography
000016901 650_2 $$2MeSH$$aCohort Studies
000016901 650_2 $$2MeSH$$aEndarterectomy, Carotid: adverse effects
000016901 650_2 $$2MeSH$$aEndarterectomy, Carotid: methods
000016901 650_2 $$2MeSH$$aFemale
000016901 650_2 $$2MeSH$$aHospital Mortality: trends
000016901 650_2 $$2MeSH$$aHumans
000016901 650_2 $$2MeSH$$aMale
000016901 650_2 $$2MeSH$$aMiddle Aged
000016901 650_2 $$2MeSH$$aOdds Ratio
000016901 650_2 $$2MeSH$$aPostoperative Complications: epidemiology
000016901 650_2 $$2MeSH$$aPostoperative Complications: physiopathology
000016901 650_2 $$2MeSH$$aProbability
000016901 650_2 $$2MeSH$$aProsthesis Failure
000016901 650_2 $$2MeSH$$aRegistries
000016901 650_2 $$2MeSH$$aRisk Assessment
000016901 650_2 $$2MeSH$$aSeverity of Illness Index
000016901 650_2 $$2MeSH$$aSocieties, Medical
000016901 650_2 $$2MeSH$$aStents
000016901 650_2 $$2MeSH$$aSurvival Analysis
000016901 650_2 $$2MeSH$$aUltrasonography, Doppler, Duplex
000016901 650_7 $$2WoSType$$aJ
000016901 65320 $$2Author$$aLead titanate
000016901 65320 $$2Author$$aNanoparticles
000016901 65320 $$2Author$$aChemical solution deposition
000016901 65320 $$2Author$$aThin films
000016901 65320 $$2Author$$aFerroelectrics
000016901 65320 $$2Author$$aReverse micelles
000016901 7001_ $$0P:(DE-Juel1)VDB3028$$aSchneller, T.$$b1$$uFZJ
000016901 7001_ $$0P:(DE-Juel1)129189$$aDornseiffer, J.$$b2$$uFZJ
000016901 7001_ $$0P:(DE-Juel1)131022$$aWaser, R.$$b3$$uFZJ
000016901 773__ $$0PERI:(DE-600)1472726-2$$a10.1007/s10971-010-2321-7$$gVol. 57, p. 36 - 42$$p36 - 42$$q57<36 - 42$$tJournal of sol gel science and technology$$v57$$x0928-0707$$y2011
000016901 8567_ $$uhttp://dx.doi.org/10.1007/s10971-010-2321-7
000016901 909CO $$ooai:juser.fz-juelich.de:16901$$pVDB:Earth_Environment$$pVDB
000016901 9131_ $$0G:(DE-Juel1)FUEK491$$bErde und Umwelt$$kP23$$lAtmosphäre und Klima$$vAtmosphäre und Klima$$x0$$zvormals P22
000016901 9131_ $$0G:(DE-Juel1)FUEK412$$bSchlüsseltechnologien$$kP42$$lGrundlagen für zukünftige Informationstechnologien (FIT)$$vGrundlagen für zukünftige Informationstechnologien$$x1
000016901 9132_ $$0G:(DE-HGF)POF3-249H$$1G:(DE-HGF)POF3-240$$2G:(DE-HGF)POF3-200$$aDE-HGF$$bMarine, Küsten- und Polare Systeme$$lAtmosphäre und Klima$$vAddenda$$x0
000016901 9132_ $$0G:(DE-HGF)POF3-529H$$1G:(DE-HGF)POF3-520$$2G:(DE-HGF)POF3-500$$aDE-HGF$$bKey Technologies$$lFuture Information Technology - Fundamentals, Novel Concepts and Energy Efficiency (FIT)$$vAddenda$$x1
000016901 9141_ $$y2011
000016901 915__ $$0StatID:(DE-HGF)0010$$aJCR/ISI refereed
000016901 9201_ $$0I:(DE-Juel1)IEK-8-20101013$$gIEK$$kIEK-8$$lTroposphäre$$x0
000016901 9201_ $$0I:(DE-Juel1)PGI-7-20110106$$gPGI$$kPGI-7$$lElektronische Materialien$$x1
000016901 9201_ $$0I:(DE-82)080009_20140620$$gJARA$$kJARA-FIT$$lJülich-Aachen Research Alliance - Fundamentals of Future Information Technology$$x2
000016901 970__ $$aVDB:(DE-Juel1)131225
000016901 980__ $$aVDB
000016901 980__ $$aConvertedRecord
000016901 980__ $$ajournal
000016901 980__ $$aI:(DE-Juel1)IEK-8-20101013
000016901 980__ $$aI:(DE-Juel1)PGI-7-20110106
000016901 980__ $$aI:(DE-82)080009_20140620
000016901 980__ $$aUNRESTRICTED
000016901 981__ $$aI:(DE-Juel1)ICE-3-20101013
000016901 981__ $$aI:(DE-Juel1)PGI-7-20110106
000016901 981__ $$aI:(DE-Juel1)VDB881